annb0t
Top 20
Bionomics Ltd
ADELAIDE, Australia, July 29, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a global, clinical stage biopharmaceutical company, today released its Quarterly Activities and ASX Appendix 4C Cashflow Reports. Highlights during the Quarter ended 30 June 2022 (Quarter) and up to the date of this announcement include:
On 6 April 2022, Bionomicsâ Executive Chairman, Dr. Errol De Souza, participated in a Fireside Chat hosted by Berenber...
>>> Read more: Quarterly Activities Report for June 2022
ADELAIDE, Australia, July 29, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a global, clinical stage biopharmaceutical company, today released its Quarterly Activities and ASX Appendix 4C Cashflow Reports. Highlights during the Quarter ended 30 June 2022 (Quarter) and up to the date of this announcement include:
On 6 April 2022, Bionomicsâ Executive Chairman, Dr. Errol De Souza, participated in a Fireside Chat hosted by Berenber...
>>> Read more: Quarterly Activities Report for June 2022
